By vgreene, 22 April, 2020 Off-label Use of Tocilizumab in Patients With SARS-CoV-2 Infections; full-text J Med Virol article
By vgreene, 22 April, 2020 Proposed mechanism: reduces inflammatory response via inhibition of multiple cytokines
By vgreene, 22 April, 2020 False (-) COVID-19 tests can occur; if high likelihood COVID-19 based on exposure, presentation—consider repeat test2
By vgreene, 22 April, 2020 False (-) COVID-19 tests can occur; if high likelihood COVID-19 based on exposure, presentation—consider repeat test2